9 Stocks Jim Cramer Talked About

6. CRISPR Therapeutics AG (NASDAQ:CRSP)

Number of Hedge Fund Holders: 27

In response to a caller’s question about CRISPR Therapeutics AG (NASDAQ:CRSP), Cramer said:

“You know, I want to own, I want to own CRISPR because I keep seeing their name come up and all the science papers that I read and I read quite a bit of them, but boy, the stock’s been a tough own. Let’s put some away and then if it goes lower, we’ll buy more. But I, I understand. How could that company keep losing money like this? It is just, it’s Moderna-like… in the money they throw in the chimney.”

CRISPR (NASDAQ:CRSP) develops gene-based medicines using its CRISPR/Cas9 platform, with therapies targeting diseases like hemoglobinopathies, cancer, and type 1 diabetes.